At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Framingham Heart Study
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Apr 14, 2016
In Brief
An observational study for Cardiovascular Diseases and 9 related conditions. Completed.
Detailed Summary
The Framingham Heart Study was initiated to study the factors associated with the development of cardiovascular disease by employing long-term surveillance of an adult population in Framingham, Massachusetts. The Framingham Offspring Study was initiated to assess familial and genetic factors as determinants of coronary heart disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Coronary Disease, Cerebrovascular Accident, Hypertension, Heart Failure, Congestive, Peripheral Vascular Diseases, Arterial Occlusive Diseases, Atherosclerosis, Heart Failure
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1947194819491950195119521953195419551956195719581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
Enrollment StartJul 1948
First PostedMay 2000
Primary CompletionSep 2008
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartJul 1, 1948
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 60.2 yearsPosted 26.1 years ago